Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

UNKNOWN × Neoplasm Metastasis × Vinorelbine × Clear all

Phase

Status

Sponsor Class

OTHER 6 INDUSTRY 6 UNKNOWN 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 3 Neoplasm Metastasis 1 Hormone Receptor Positive Advanced Breast Cancer 1 Carcinoma, Ductal, Breast 1 Brain Neoplasms 1

Interventions

Capecitabine 3 Docetaxel 2 sintilimab 1 Vinorelbine 1 Platinum Compounds 1 Oxaliplatin 1 Irinotecan 1 Etoposide 1 Drug Therapy 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01126138 2011-05-04

Capecitabine (NX) Versus Docetaxel Plus Capecitabine (TX) as 1-line Chemotherapy on Metastatic Breast Cancer (MBC)

ChineseAMS

Phase 3 Unknown

Breast Neoplasms, Neoplasm Metastasis, Carcinoma, Ductal, Breast

Data powered by HemOnc (CC BY 4.0) Colophon ⚡